Jeanne Lenzer

2 months ago | jacobin.com | Jeanne Lenzer

Six years ago, Genevieve Lane was enjoying an active life in Florida when she began to forget her neighbors’ names and where she put her keys. At seventy-six, she might have shrugged off these lapses as mere signs of aging, but when she began to have moments of confusion and occasionally got lost while out walking, her housemate and longtime friend Vicki Holmes told her about a nearby research center.

2 months ago | levernews.com | Jeanne Lenzer

This article is part of an investigation into the Food and Drug Administration’s drug approval process and what it means for the public’s safety and health. The project is supported by The Lever and the McGraw Center for Business Journalism at CUNY Newmark School of Journalism. Six years ago, Genevieve Lane was enjoying an active life in Florida when she began to forget her neighbors’ names and where she put her keys.

2 months ago | levernews.com | Jeanne Lenzer

This full story is for paid subscribers. Sign up for a paid subscription to The Lever now to gain access to this story and more. Already have an account? Sign in

Nov 15, 2024 | bmj.com | Jeanne Lenzer |Shannon Brownlee

Dear Editor,We respond to four points made by Teresa J Buracchio et al, on behalf of the FDA:First, regarding financial conflictsThe FDA leaves out important information regarding the agency’s increasing reliance on advisory committee members who have ties to drug and medical device makers.

Jun 14, 2023 | bmj.com | Jeanne Lenzer